vemurafenib + cobimetinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for vemurafenib + cobimetinib, covering 2018-11-07 to 2018-11-07. Get the full timeline:
Most recent: Clinical Trial Update: The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma [Phase 2]